share_log

*ST科华(002022.SZ)获得“人类免疫缺陷病毒抗原抗体质控品”医疗器械注册证

*ST Kehua (002022.SZ) obtained the “Human Immunodeficiency Virus Antigen Antibody Quality Control Product” medical device registration certificate

Zhitong Finance ·  Mar 15, 2023 17:00

According to the Zhitong Finance App, *ST Kehua (002022.SZ) issued an announcement. Recently, the company received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the China Drug Administration. The product is: “Human Immunodeficiency Virus Antigen Antibody Quality Control Product”, which complements the company's human immunodeficiency virus antigen antibody (HIVag/Ab) test kit (chemiluminescence) for the quality control of the human immunodeficiency virus antigen antibody test project.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment